Atezolizumab for PD-L1-Selected Patients with NSCLC. Reply
- PMID: 33567202
- DOI: 10.1056/NEJMc2032432
Atezolizumab for PD-L1-Selected Patients with NSCLC. Reply
Comment on
-
Atezolizumab for PD-L1-Selected Patients with NSCLC.N Engl J Med. 2021 Feb 11;384(6):583-584. doi: 10.1056/NEJMc2032432. N Engl J Med. 2021. PMID: 33567200 No abstract available.
-
Atezolizumab for PD-L1-Selected Patients with NSCLC.N Engl J Med. 2021 Feb 11;384(6):584. doi: 10.1056/NEJMc2032432. N Engl J Med. 2021. PMID: 33567201 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials